Disparities in liver transplantation for metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma

Figure 5 Outcomes stratified by United Network for Organ Sharing region. A: Proportion of patients with non-alcoholic steatohepatitis-associated hepatocellular carcinoma undergoing liver transplantation, by region and race/ethnicity; B: Proportion of patients dying on the liver transplant waitlist for non-alcoholic steatohepatitis-associated hepatocellular carcinoma, by region and race/ethnicity.